Gene Engineering T Cells with T-Cell Receptor for Adoptive Therapy

Area of Science:

• Immunology
• Molecular Biology
• Biotechnology

Background:

• Adoptive T-cell therapy using T-cell receptor (TCR)-engineered T cells shows promise for cancer treatment.
• Preclinical evaluation of TCRs is crucial for ensuring safety and efficacy before clinical application.

Purpose of the Study:

• To present a comprehensive set of protocols for the preclinical assessment of TCRs.
• To facilitate the selection of optimal TCR candidates for clinical testing in adoptive T-cell therapy.

Main Methods:

• TCR retrieval and annotation.
• Gene transfer into T cells.
• In vitro assessment of TCR specificity and sensitivity.
• Evaluation of critical preclinical parameters.

Main Results:

• Established a series of fundamental protocols for TCR preclinical evaluation.
• Demonstrated a method for assessing target recognition specificity and sensitivity.
• Enabled informed selection of TCRs for clinical development.

Conclusions:

• The presented protocols are essential for the rigorous preclinical evaluation of TCRs.
• This framework supports the advancement of TCR-engineered T-cell therapies towards clinical application.